Company profile PBYI
After 38 days of this quarter the interest is at 53.0. Based on that we can calculate that during remaining 53 days it will total up to 127.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 44 | 68 54.5% QoQ | 153 125.0% QoQ | 219 43.1% QoQ |
| 2020 | 128 190.9% YoY -41.6% QoQ | 109 60.3% YoY -14.8% QoQ | 66 -56.9% YoY -39.4% QoQ | 144 -34.2% YoY 118.2% QoQ |
| 2021 | 27 -78.9% YoY -81.2% QoQ | 210 92.7% YoY 677.8% QoQ | 91 37.9% YoY -56.7% QoQ | 248 72.2% YoY 172.5% QoQ |
| 2022 | 17 -37.0% YoY -93.1% QoQ | 60 -71.4% YoY 252.9% QoQ | 123 35.2% YoY 105.0% QoQ | 133 -46.4% YoY 8.1% QoQ |
| 2023 | 98 476.5% YoY -26.3% QoQ | 38 -36.7% YoY -61.2% QoQ | 69 -43.9% YoY 81.6% QoQ | 184 38.3% YoY 166.7% QoQ |
| 2024 | 53 -45.9% YoY -71.2% QoQ | - | - | - |
The average 5 years interest of Puma Biotechnology news was 8.78 per week. The last year interest of Puma Biotechnology news compared to the last 5 years has changed by -13.21%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -24.55%.
There is not enough data for Puma Biotechnology drugs to provide analysis
There is not enough data for Puma Biotechnology drugs to provide correlation calculation
There is not enough data for Puma Biotechnology drugs to provide analysis
There is not enough data for Puma Biotechnology neratinib to provide analysis
There is not enough data for Puma Biotechnology neratinib to provide correlation calculation
There is not enough data for Puma Biotechnology neratinib to provide analysis
There is not enough data for Puma Biotechnology cancer care to provide analysis
There is not enough data for Puma Biotechnology cancer care to provide correlation calculation
There is not enough data for Puma Biotechnology cancer care to provide analysis
There is not enough data for Puma Biotechnology HER2-positive breast cancer to provide analysis
There is not enough data for Puma Biotechnology HER2-positive breast cancer to provide correlation calculation
There is not enough data for Puma Biotechnology HER2-positive breast cancer to provide analysis
There is not enough data for Puma Biotechnology trials to provide analysis
There is not enough data for Puma Biotechnology trials to provide correlation calculation
There is not enough data for Puma Biotechnology trials to provide analysis
There is not enough data for Puma Biotechnology Pfizer agreement to provide analysis
There is not enough data for Puma Biotechnology Pfizer agreement to provide correlation calculation
There is not enough data for Puma Biotechnology Pfizer agreement to provide analysis
There is not enough data for Puma Biotechnology headquarters location to provide analysis
There is not enough data for Puma Biotechnology headquarters location to provide correlation calculation
There is not enough data for Puma Biotechnology headquarters location to provide analysis
There is not enough data for Puma Biotechnology stock -company to provide analysis
There is not enough data for Puma Biotechnology stock -company to provide correlation calculation
There is not enough data for Puma Biotechnology stock -company to provide analysis